Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 18 Oct 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
| 18 Oct 2024 07:00 CEST |
STRONGPOINT | StrongPoint ASA: Third Quarter Results 2024 | 10101010 Computer Services | Half yearly financial reports and audit reports/limited reviews |
| 18 Oct 2024 07:00 CEST |
MAGNORA | Magnora ASA: Ex distribution NOK 0.187 today | 60102020 Renewable Energy Equipment | Ex Date |
| 18 Oct 2024 07:00 CEST |
ATLANTIC SAPPHIRE | Atlantic Sapphire ASA: Information about the warrants to be listed | 45102010 Farming, Fishing, Ranching and Plantations | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Oct 2024 07:00 CEST |
MON COURTIER ENERGIE GROUPE S.A. | Mon courtier énergie groupe annonce ses résultats semestriels 2024 | 50205020 Professional Business Support Services | Income |
| 18 Oct 2024 07:00 CEST |
MON COURTIER ENERGIE GROUPE S.A. | Mon Courtier Energie Groupe Announces Its First-Half 2024 Results | 50205020 Professional Business Support Services | Income |
| 18 Oct 2024 06:59 CEST |
NORSKE SKOG | Finansiell kalender | 55101015 Paper | Annen informasjonspliktig regulatorisk informasjon |
| 18 Oct 2024 06:59 CEST |
NORSKE SKOG | Financial calendar | 55101015 Paper | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Oct 2024 06:55 CEST |
NORSKE SKOG | Høyere markedsandel i utfordrende markeder for publikasjonspapir | 55101015 Paper | Annen informasjonspliktig regulatorisk informasjon |
| 18 Oct 2024 06:55 CEST |
NORSKE SKOG | Higher market share in challenging publication paper market | 55101015 Paper | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Oct 2024 03:43 CEST |
RAPID NUTRITION | Rapid Nutrition PLC - Résultats de l'Assemblée Générale tenue le 18 octobre 2024 | 45102020 Food Products | General meeting / Board Meeting |
| 18 Oct 2024 03:40 CEST |
RAPID NUTRITION | Rapid Nutrition PLC - Results of General Meeting held 18 October 2024 | 45102020 Food Products | General meeting / Board Meeting |
| 17 Oct 2024 21:30 CEST |
SALMONES CAMANCHACA S.A. | Trading Update Q3 2024 | 45102010 Farming, Fishing, Ranching and Plantations | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Oct 2024 21:11 CEST |
BE Semiconductor Industries N.V. | BE Semiconductor Industries N.V. Announces 2024 Third Quarter Conference Call and Webcast Details | 10102010 Semiconductors | Other subject |
| 17 Oct 2024 20:54 CEST |
SAFE | Signature d’un avenant n°3 au contrat de financement obligataire en vigueur pour assurer le retournement stratégique de Safe | 20102015 Medical Supplies | - |
| 17 Oct 2024 20:53 CEST |
ALTRI SGPS | ALTRI, S.G.P.S., S.A. informa sobre transações de dirigentes | 55101015 Paper | Other subject |
| 17 Oct 2024 20:45 CEST |
VEON | VEON Files its 2023 Form 20-F | 15102015 Telecommunications Services | Other subject |
| 17 Oct 2024 20:39 CEST |
AIRTHINGS | Airthings ASA: Invitation to the presentation of the Q3 2024 results | 50202025 Electronic Equipment: Gauges and Meters | Non-regulatory press releases |
| 17 Oct 2024 19:49 CEST |
EUTELSAT COMMUNIC. | EUTELSAT COMMUNICATIONS : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL POUR L’EXERCICE CLOS LE 30 JUIN 2024 | 15101010 Telecommunications Equipment | Other subject |
| 17 Oct 2024 19:49 CEST |
EUTELSAT COMMUNIC. | Eutelsat Communications: Notice of Availability of the Universal Registration Document for the Year Ending June 30, 2024 | 15101010 Telecommunications Equipment | Other subject |
| 17 Oct 2024 19:48 CEST |
EQVA ASA | Eqva ASA: Redelivery of borrowed shares to close associate of primary insider | 50206030 Marine Transportation | Mandatory notification of trade primary insiders |
| 17 Oct 2024 19:32 CEST |
NEXT BIOMETRICS GROUP | NEXT Biometrics Group ASA – Registration of new share capital | 10102015 Electronic Components | Total number of voting rights and capital |
| 17 Oct 2024 19:28 CEST |
AB SCIENCE | AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS | 20103010 Biotechnology | New |
| 17 Oct 2024 19:28 CEST |
AB SCIENCE | AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA | 20103010 Biotechnology | New |
| 17 Oct 2024 18:44 CEST |
CASINO GUICHARD | Casino Group: Statutory buyout proceedings - Cnova | 45201010 Food Retailers and Wholesalers | New |
| 17 Oct 2024 18:44 CEST |
CASINO GUICHARD | Groupe Casino : Procédure de rachat obligatoire - Cnova | 45201010 Food Retailers and Wholesalers | New |
| 17 Oct 2024 18:39 CEST |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |
| 17 Oct 2024 18:30 CEST |
RUBIS | RUBIS: Rubis completes the sale of its 55% stake in Rubis Terminal (now branded Tepsa) | 40401030 Specialty Retailers | Mergers, Acquiqitions, Transferts |
| 17 Oct 2024 18:30 CEST |
RUBIS | RUBIS: Rubis finalise la cession de sa participation de 55 % dans Rubis Terminal (désormais appelé Tepsa) | 40401030 Specialty Retailers | Mergers, Acquiqitions, Transferts |
| 17 Oct 2024 18:30 CEST |
MEMSCAP REGPT | MEMSCAP : VISIOCONFERENCE ACTIONNAIRES ET INVESTISSEURS LUNDI 28 OCTOBRE 2024 18H00 | 10102010 Semiconductors | Meetings / events |
| 17 Oct 2024 18:29 CEST |
INTEGRAGEN | IntegraGen : Résultats du 1er semestre 2024 – Chiffre d’affaires en hausse de 6% à périmètre constant (hors SeqOIA) et rentabilité maintenue | 20103010 Biotechnology | Income |
| 17 Oct 2024 18:29 CEST |
INTEGRAGEN | IntegraGen: 2024 Half-Year Results - Sales up 6% on a Like-for-Like Basis (Excluding SeqOIA) and Profitability Maintained | 20103010 Biotechnology | Income |
| 17 Oct 2024 18:17 CEST |
FDJ | La Française des Jeux : Chiffre d’affaires à fin septembre en hausse de +12 % et +6 % à périmètre comparable | 40501020 Casinos and Gambling | Sales |
| 17 Oct 2024 18:17 CEST |
FDJ | La Française des Jeux: Revenue to End-September up 12%, and 6% on a Like-for-like Basis | 40501020 Casinos and Gambling | Sales |
| 17 Oct 2024 18:00 CEST |
BIOSYNEX | BIOSYNEX SA: RESULTATS SEMESTRIELS 2024 - FINALISATION DU PLAN DE RATIONALISATION DES COUTS ET DE REAMENAGEMENT DE LA DETTE SUR LES PROCHAINS MOIS | 20102010 Medical Equipment | Income |
| 17 Oct 2024 18:00 CEST |
I2S | i2S : Chiffre d\'affaires 9 mois 2024 | 50202025 Electronic Equipment: Gauges and Meters | Share history |
| 17 Oct 2024 18:00 CEST |
OSMOSUN S.A. | 10 million M3 of fresh water produced for the OSMOSUN desalination plant at Lake Ghoubet in Djibouti | 65102030 Water | Legal |
| 17 Oct 2024 18:00 CEST |
ESSILORLUXOTTICA | EssilorLuxottica: Chiffre d’affaires T3/9M 2024 - Solide croissance du chiffre d'affaires à +4 % | 20102015 Medical Supplies | Commercial results |
| 17 Oct 2024 18:00 CEST |
TELEPERFORMANCE | Teleperformance’s New Carbon Emissions Targets Approved by Science Based Targets Initiative | 50205020 Professional Business Support Services | Products and services |
| 17 Oct 2024 18:00 CEST |
OSE IMMUNOTHERAPEUTICS | OSE Immunotherapeutics présente une nouvelle technologie bispécifique de « Cis-Démasquage » pour la conception de médicaments à base de cytokines avec un indice thérapeutique amélioré | 20103010 Biotechnology | Other subject |
| 17 Oct 2024 18:00 CEST |
LLAMA GROUP | Llama Group : Faits marquants du premier semestre 2024 | 40203040 Electronic Entertainment | New |
| 17 Oct 2024 18:00 CEST |
European Medical Solutions | CHIFFRE D'AFFAIRES DU 3ÈME TRIMESTRE 2024 : EMS POURSUIT SA CROISSANCE | 20103010 Biotechnology | Sales, Income |
| 17 Oct 2024 18:00 CEST |
THERANEXUS | THERANEXUS S'ASSOCIE À SYNERLAB POUR PRÉPARER LA COMMERCIALISATION DE SA FORMULATION PÉDIATRIQUE DANS LA MALADIE DE NIEMANN-PICK DE TYPE C | 20103010 Biotechnology | Legal |
| 17 Oct 2024 18:00 CEST |
ESSILORLUXOTTICA | EssilorLuxottica: Fatturato del terzo trimestre e dei nove mesi 2024 - Solida traiettoria di crescita, fatturato in aumento del 4% | 20102015 Medical Supplies | Commercial results |
| 17 Oct 2024 18:00 CEST |
DIAGNOSTIC MEDICAL SYSTEMS | CHIFFRE D'AFFAIRES DU 3ÈME TRIMESTRE 2024 : DMS GROUP POURSUIT SA CROISSANCE | 20102010 Medical Equipment | Sales, Income |
| 17 Oct 2024 18:00 CEST |
ESSILORLUXOTTICA | EssilorLuxottica: Q3/9M 2024 Revenue - Revenue keeping a solid 4% growth | 20102015 Medical Supplies | Commercial results |
| 17 Oct 2024 18:00 CEST |
TELEPERFORMANCE | L’initiative Science Based Targets valide les nouveaux objectifs d’émissions carbone de Teleperformance | 50205020 Professional Business Support Services | Products and services |
| 17 Oct 2024 18:00 CEST |
OSE IMMUNOTHERAPEUTICS | OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology for the Design of Cytokine Drugs with Improved Therapeutic Index | 20103010 Biotechnology | Other subject |
| 17 Oct 2024 18:00 CEST |
OSMOSUN S.A. | 10 millions de M3 d'eau douce produite pour l'unité de dessalement OSMOSUN du Lac du Goubet à Djibouti | 65102030 Water | Legal |
| 17 Oct 2024 18:00 CEST |
THERANEXUS | THERANEXUS JOINS UP WITH SYNERLAB TO PREPARE THE COMMERCIALIZATION OF ITS PEDIATRIC FORMULATION IN NIEMANN-PICK TYPE C DISEASE | 20103010 Biotechnology | Legal |